The Global Age-Related Macular Degeneration Market was valued at US$ 11.31 billion in 2023 and is expected to reach a market size of US$ 19.72 billion by 2032 at a CAGR of 7.2% During the Forecast ...
This CHMP opinion was made despite broad support for pegcetacoplan from the European retina community and multiple dissenting votes by CHMP members who supported a path to approval.” “We have seen the ...